Aurobindo, Hetero, and Vivimed Class Action Settlements in Oregon
Aurobindo, Hetero, and Vivimed class action settlements that covered Oregon residents — and where each one now stands.
Last checked: August 11, 2026 · By Class Action Buddy
Oregon residents have no confirmed open class action settlements involving Aurobindo, Hetero, and Vivimed right now. The Aurobindo, Hetero, and Vivimed settlement below has closed — the claim deadline has passed and no new claims can be filed. If you are looking for something you can still claim, our list of open settlements is checked against each administrator.
Class Action Buddy fills in official claim forms from your saved profile in under 60 seconds, then prints and posts the completed claim for you. There is nothing to file against Aurobindo, Hetero, and Vivimed at the moment — see what is open now.
Closed Aurobindo, Hetero, and Vivimed Settlements for Oregon Residents (1)
This Aurobindo, Hetero, and Vivimed settlement is no longer accepting claims. It closed on the date shown and the deadline cannot be reopened. It is listed here because the settlement and its administrator are a matter of record and people still search for it. For settlements that are open today, see our list of open settlements.
$15.2M Valsartan, Losartan and Irbesartan class action settlement
Up to TBDFile your claim for the $15.2M Valsartan, Losartan, and Irbesartan settlement. Blood pressure medication contaminated with cancer-causing substances.
About Aurobindo, Hetero, and Vivimed Class Actions in Oregon
Before you read on: the Aurobindo, Hetero, and Vivimed settlement described below has closed. This section explains what it was about and who was covered, which is still worth knowing — but it cannot be claimed now. See settlements that are open today.
Oregon residents affected by contaminated blood pressure medications from Aurobindo, Hetero, and Vivimed have specific protections under state law. Oregon's Unlawful Trade Practices Act provides broader consumer protections than federal regulations, allowing residents to pursue additional damages beyond standard class action recoveries. These pharmaceutical companies distribute their generic medications throughout Oregon via major pharmacy chains and healthcare systems, with Aurobindo maintaining significant market share in the Pacific Northwest region. Oregon residents filing class action claims must typically demonstrate they purchased the specific recalled lots of valsartan, losartan, or irbesartan containing NDMA contamination. The state's consumer protection framework requires companies to provide clear notification of recalls, and failure to do so can result in additional penalties. Oregon's statute of limitations for product liability claims is generally two years from discovery of harm, though class action settlements may extend these deadlines. The $15.2 million settlement covering these three manufacturers specifically addresses NDMA-contaminated medications distributed nationwide, including Oregon pharmacies between 2014-2019.
Aurobindo, Hetero, and Vivimed Settlements in Oregon: FAQs
How does Oregon's consumer protection law affect my Aurobindo, Hetero, or Vivimed settlement claim?
Oregon's Unlawful Trade Practices Act may provide additional remedies beyond the $15.2 million class action settlement for contaminated blood pressure medications. This state law allows Oregon residents to potentially recover attorney fees and punitive damages if these manufacturers violated Oregon's specific consumer protection standards.
Are Oregon residents automatically included in the Aurobindo, Hetero, and Vivimed valsartan settlement?
Oregon residents who purchased contaminated valsartan, losartan, or irbesartan from these manufacturers between 2014-2019 are included in the nationwide settlement class. You must submit a valid claim form with proof of purchase from Oregon pharmacies to receive compensation from the $15.2 million settlement fund.
What documentation do Oregon residents need for Aurobindo, Hetero, and Vivimed claims?
Oregon claimants need pharmacy records, prescription bottles, or insurance documentation showing purchase of recalled medications from these three manufacturers. Oregon's electronic prescription monitoring system may help verify purchases if you lack original documentation.
Tips for Oregon Residents Filing Aurobindo, Hetero, and Vivimed Claims
Oregon residents filing claims against Aurobindo, Hetero, and Vivimed should gather all pharmacy records from 2014-2019 showing purchases of contaminated valsartan, losartan, or irbesartan. Contact your Oregon pharmacy directly for detailed prescription histories, as many retain records beyond standard requirements. Submit claims promptly, as settlement deadlines are typically non-negotiable. Consider consulting Oregon attorneys familiar with pharmaceutical class actions, especially if you experienced health complications. Oregon's consumer protection laws may provide additional recovery options beyond the primary settlement. Keep copies of all medical records linking your health issues to contaminated medications, as future litigation may emerge.
File Aurobindo, Hetero, and Vivimed Claims in 60 Seconds
Class Action Buddy auto-fills your claim forms and submits them electronically. Your first claim is free.
